NASDAQ:ITRM   Iterum Therapeutics plc
Needs to be able to maintain price above the .382 fib level at $2.58, should be able to here in the coming weeks, longer term target of $6 for me.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.